RxDoctor Payments Data

Wolfgang Gaertner

Colon & Rectal Surgery · Minneapolis, MNNPI 1083857148

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (49.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 78.5% of it on its own, with 8 other manufacturers making up the rest. Among colon & rectal surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,030in general payments, 2019–2025

Across 160 payments — averaging $1000.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$126K
  • Coloplast$32K
  • Gyrus ACMI, Inc.$1K
  • Davol Inc.$548
  • Dilon Technologies, Inc.$162
  • Olympus Corporation Of The Americas$101
  • plus $110 from 3 others
$37,175in research payments, 2019–2025

Across 4 payments — averaging $9293.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Davol Inc.$35K
  • Intuitive Surgical Operations, Inc.$2K

What the payments were for

  • Consulting fees$24,08015%
  • Speaking & faculty fees$30,00019%
  • Travel & lodging$21,34113%
  • Food & beverage$5,5663%
  • Education$79,04349%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$160,030 in reported general payments places this provider in the 95th percentile of 64 colon & rectal surgery providers in Minnesota.

See all colon & rectal surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$36,549
Medicare patients
86
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl26$673
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl17$475
Neomycin Sulfate23$136
Metronidazole31$70
Ondansetron Hcl27$35

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →